• Modus


'Brexit' is creating an uncertain time for all industries especially those which rely so heavily on relations with the EU – however regardless of the outcome, Parallel Imports of pharmaceuticals will continue.

The UK submitted the notification of its intention to withdraw from the European Union pursuant to Article 50 of the Treaty on European Union on 29 March 2017.

Until the UK leaves the EU or Article 50 is extended or revoked, the UK remains a full member of the EU and all the rights and obligations of EU membership remain in force.

If the UK leaves the EU without a deal (“no-deal”), regulation of medicines, medical devices and clinical trials will be affected. 

Further information on 'Brexit' can be found here.

#brexit #eu #uk #article50 #nodeal

Don't hesitate to contact us to see how we can support you.

© 2020 by MODUS Consultancy Ltd

Proudly created with Wix.com

+44(0)7894 712912 
+44(0)7403 756965
Original on Transparent.png